Dr. Akash Deep is the Director of the Paediatric Intensive Care Unit at King's College Hospital, London. He is also the chair of the Renal / CRRT Section of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC), and chair of the UK Paediatric Intensive Care Society’s Science and Education Committee. Dr. Deep conducts workshops and seminars on AKI and CRRT in various parts of the world. He was the co-chairman of the 8th and 9th International conferences on pediatric CRRT hosted in London and Orlando respectively. He regularly teaches on the winter and summer schools of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). ?His main interests include AKI in liver disease and RRT and other liver assist devices in liver failure and he has published on both of these topics extensively.
Dr. Deep is a clinical expert on paediatric sepsis and an advisor for the UK sepsis Trust. He works with a team of national and international experts who collaborate with the UK sepsis Trust, Royal College of Paediatrics and Child Health and World Federation of Intensive Care.
Dr. Deep is the main author of the widely acclaimed ''Paediatric sepsis toolkit'' for emergency departments, which was launched at the House of Commons in 2015. Dr. Deep offers clinicians involved in its implementation in the UK regular teaching sessions, introducing sepsis pocket cards . He is member of the most prestigious societies and author of several articles and book chapters.
Dr. Stuart L. Goldstein is the Clark D. West Endowed Chair, Director of the Center for Acute Care Nephrology, Medical Director of the Pheresis Service, Co-Medical Director of the Heart Institute Research Core at Cincinnati Children’s Hospital Medical Center and the Professor of Pediatrics at the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Dr. Goldstein has been an active investigator in the field of pediatric acute kidney injury (AKI) since 2000. Dr. Goldstein’s main research foci include AKI epidemiology and outcomes, acute renal replacement therapy provision and investigation of novel urinary AKI biomarkers in the pediatric population. Dr. Goldstein has established a strong record of interdisciplinary and inter-institutional collaboration with cardiologists, intensivists and emergency center physicians, which is evidenced by his establishment and directing of the Prospective Pediatric Continuous Renal Replacement Therapy Registry from 2001 to 2012, and the Prospective Pediatric AKI Research Group (ppAKI-RG) in 2012. Dr. Goldstein is also a respected educator; he has developed the only pediatric-specific acute care nephrology sub-specialty fellowship with graduates who are now leaders in the field of pediatric AKI. He is member of the most prestigious societies and has published 200 papers in international journals as well as 30 book chapters.